VRTX
Vertex Pharmaceuticals Incorporated
Stock
$504.73−2.01 (−0.40%)Close Oct 2, 2026
- Free cash flow, 2025
- $3.2B
- 5-year CAGR
- +1.3%
Free cash flow
Free cash flow by fiscal year
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | $3.2B | — |
| 2024 | −$790M | — |
| 2023 | $3.3B | −15.0% |
| 2022 | $3.9B | +63.0% |
| 2021 | $2.4B | −19.5% |
| 2020 | $3.0B | +100.4% |
| 2019 | $1.5B | +27.2% |
| 2018 | $1.2B | +57.6% |
| 2017 | $746M | +315.2% |
| 2016 | $180M | — |
| 2015 | −$411M | — |
| 2014 | −$624M | — |
| 2013 | −$112M | — |
| 2012 | $197M | +80.2% |
| 2011 | $109M | — |
| 2010 | −$673M | — |
| 2009 | −$451M | — |
| 2008 | −$259M | — |